FDA Drug Application (075227) for NAPROXEN by TEVA

Back to FDA Applications sponsored by TEVA

Application Number075227
Product Number001
FormTABLET, DELAYED RELEASE;ORAL
Dosage375MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameNAPROXEN
Active IngredientNAPROXEN



Back to FDA Applications sponsored by TEVA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.